Some individuals may notice weight loss within a few weeks of starting the medication, while others may take a few months to see significant changes
GLP-1 R activation has been shown to elevate cAMP levels, activating PKA and Epac pathways, which offer antioxidant and anti-apoptotic protection against oxidative damage
Formulation: BP-C1-57 (10mg), TB-500 (10mg), GHK-Cu (50mg), KPV (10mg)
What lifestyle habits will you establish during treatment that will sustain your weight loss if and when you stop the medication
The goal during GLP-1 therapy is not simply caloric restriction it is nutrient-preserving weight loss
Glucagon receptor activation increases energy expenditure and may promote hepatic fat reduction, which could offer additional benefits for conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD, previously known as NAFLD)